Yuankai Shi, Xiaoyong Tang, Lin Wu, Wei Guo, Yanping Hu, Honghai Wang, Shiguang Xie, Qingshan Li, Yu Yao, Yan Wang. "A randomized, open-label, parallel-controlled phase 3 trial of benmelstobart plus chemotherapy and anlotinib for first-line treatment of advanced non-squamous non–small cell lung cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba8507